Histone lysine demethylase KDM5B facilitates proliferation and suppresses apoptosis in human acute myeloid leukemia cells through the miR-140-3p/BCL2 axis
RNA · 2024-04 · 30 (4) · 435-447
DOI: 10.1261/rna.079865.123 ↗Kurz gefasst
Fachartikel in der Zeitschrift RNA, online erschienen am 31.01.2024. Verfasst von Jiaojuan Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, MicroRNAs. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The histone lysine demethylase KDM5B is frequently up-regulated in various human cancer cells. However, its expression and functional role in human acute myeloid leukemia (AML) cells remain unclear. Here, we found that the expression level of KDM5B is high in primary human AML cells. We have demonstrated that knocking down KDM5B leads to apoptosis and impairs proliferation in primary human AML and some human AML cell lines. We further identified miR-140-3p as a downstream target gene of KDM5B. KDM5B expression was inversely correlated with the miR-140-3p level in primary human AML cells. Molecular studies showed that silencing KDM5B enhanced H3K4 trimethylation (H3K4me3) at the promoter of miR-140-3p, leading to high expression of miR-140-3p, which in turn inhibited B-cell CLL/lymphoma 2 (BCL2) expression. Finally, we demonstrate that the defective proliferation induced by KDM5B knockdown (KD) can be rescued with the miR-140-3p inhibitor or enhanced by combining KDM5B KD with a BCL2 inhibitor. Altogether, our data support the conclusion that KDM5B promotes tumorigenesis in human AML cells through the miR-140-3p/BCL2 axis. Targeting the KDM5B/miR-140-3p/BCL2 pathway may hold therapeutic promise for treating human AML.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
- Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
- Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
- Department of Clinical Laboratory, Institute of Translational Medicine, Renmin Hospital of Wuhan University, Wuhan 430060, China.
- Department of Galactophore, Xinxiang First People's Hospital, Xinxiang 453000, China.
- School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China jingqu@hust.edu.cn zhenhua@hust.edu.cn.
ORCID-Profile: Jiaojuan Huang, Shuiling Jin, Rongqun Guo, Wei Wu, Yali Qin, Qingchuan Chen, Ximiao He, Jing Qu, Zhenhua Yang
Zitieren
APA
Huang, J., Jin, S., Guo, R., Wu, W., Yang, C., Qin, Y., Chen, Q., He, X., Qu, J., & Yang, Z. (2024). Histone lysine demethylase KDM5B facilitates proliferation and suppresses apoptosis in human acute myeloid leukemia cells through the miR-140-3p/BCL2 axis. RNA, 30(4), 435-447. https://doi.org/10.1261/rna.079865.123
Vancouver
Huang J, Jin S, Guo R, Wu W, Yang C, Qin Y, et al. Histone lysine demethylase KDM5B facilitates proliferation and suppresses apoptosis in human acute myeloid leukemia cells through the miR-140-3p/BCL2 axis. RNA. 2024;30(4):435-447. doi:10.1261/rna.079865.123
BibTeX
@article{Huang2024,
author = {Huang, Jiaojuan and Jin, Shuiling and Guo, Rongqun and Wu, Wei and Yang, Chengxuan and Qin, Yali and Chen, Qingchuan and He, Ximiao and Qu, Jing and Yang, Zhenhua},
title = {Histone lysine demethylase KDM5B facilitates proliferation and suppresses apoptosis in human acute myeloid leukemia cells through the miR-140-3p/BCL2 axis},
journal = {RNA},
year = {2024},
volume = {30},
number = {4},
pages = {435--447},
doi = {10.1261/rna.079865.123}
}
EUVIMED